IDBS to Acquire InforSense to Expand Integration Offering, Life Science Presence

IDBS said the acquisition will allow it to "expand its large scale data integration activities to support international data sharing and broaden its life sciences portfolio into the emerging growth area of biomarker development and personalized medicine."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.